Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood [PDF]
Miranda Quintero J +8 more
europepmc +1 more source
Multivalent Protein Nanorings for Broad and Potent SARS-CoV-2 Neutralization. [PDF]
Behbahanipour M +11 more
europepmc +1 more source
[Successes and challenges in achieving and sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Americas, 2013-2023Conquistas e desafios para alcançar e manter a eliminação do sarampo, da rubéola e da síndrome da rubéola congênita na Região das Américas, 2013-2023]. [PDF]
Pastor D +5 more
europepmc +1 more source
[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [PDF]
Saza-Londoño W +7 more
europepmc +1 more source
Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]
Sauré D +10 more
europepmc +1 more source
[Lessons learned in the implementation of measles and rubella vaccination campaigns in the AmericasLições aprendidas com a implementação de campanhas de vacinação contra sarampo e rubéola na Região das Américas]. [PDF]
Durón R +3 more
europepmc +1 more source
[Communicating Vaccine-related Events: Experiences with ESAVIComunicação de eventos relacionados a vacinas: experiências com ESAVI]. [PDF]
López Morales EC, Cerón Coral C.
europepmc +1 more source
[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla]. [PDF]
Huerta-Rojas JA +3 more
europepmc +1 more source
The Trend of Japanese Encephalitis in Uttar Pradesh, India. [PDF]
Verma A +4 more
europepmc +1 more source

